Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605543526 | ||
| 003 | CHVBK | ||
| 005 | 20210128100927.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s00109-015-1292-0 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s00109-015-1292-0 | ||
| 245 | 0 | 0 | |a Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts |h [Elektronische Daten] |c [Anna Laurenzana, Francesca Cencetti, Simona Serratì, Gennaro Bruno, Lukasz Japtok, Francesca Bianchini, Eugenio Torre, Gabriella Fibbi, Mario Del Rosso, Paola Bruni, Chiara Donati] |
| 520 | 3 | |a The interaction between endothelial cells and pericytes is crucial for the stabilization of newly formed vessels in angiogenesis. The comprehension of the mechanisms regulating pericyte recruitment might open therapeutical perspectives on vascular-related pathologies. Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that derives from sphingomyelin catabolism and regulates biological functions in cell survival, proliferation, and differentiation. In this study, we aimed to identify the role of S1P axis in the intercellular communication between human mesenchymal progenitor mesoangioblasts (MAB) and endothelial cells (human microvascular endothelial cells (H-MVEC)) in the formation of capillary-like structures. We demonstrated that the S1P biosynthetic pathway brought about by sphingosine kinases (SK) SK1 and SK2 as well as spinster homolog 2 (SPNS2) transporter in H-MVEC is crucial for MAB migration measured by Boyden chambers and for the formation and stabilization of capillary-like structures in a 3D Matrigel culture. Moreover, the conditioned medium (CM) harvested from H-MVEC, where SK1, SK2, and SPNS2 were down-regulated, exerted a significantly diminished effect on MAB capillary morphogenesis and migration. Notably, we demonstrated that S1P1 and S1P3 receptors were positively involved in CM-induced capillary-like formation and migration, while S1P2 exerted a negative roleon CM-induced migratory action of MAB. Finally, SK inhibition as well as MAB S1P1 and S1P3 down-regulation impaired H-MVEC-MAB cross-talk significantly reducing in vivo angiogenesis evaluated by Matrigel plug assay. These findings individuate novel targets for the employment of MAB in vascular-related pathologic conditions. Key message: • Down-regulation of SK1/2 in H-MVEC impaired vessel formation when cultured with MAB. • H-MVEC SPNS2 is critical for morphogenesis and migration induced by H-MVEC CM of MAB. • CM from SK1- and SK2-siRNA H-MVEC impaired morphogenesis and migration of MAB. • S1P1/3 were involved on CM-induced morphogenesis and migration of MAB. • Matrigel plug assay showed the role of S1P axis in MAB-endothelial cell interaction. | |
| 540 | |a Springer-Verlag Berlin Heidelberg, 2015 | ||
| 690 | 7 | |a Mesoangioblasts |2 nationallicence | |
| 690 | 7 | |a Endothelial cells |2 nationallicence | |
| 690 | 7 | |a Sphingosine kinase |2 nationallicence | |
| 690 | 7 | |a Migration |2 nationallicence | |
| 690 | 7 | |a Morphogenesis |2 nationallicence | |
| 690 | 7 | |a SK : Sphingosine kinase |2 nationallicence | |
| 690 | 7 | |a S1P : Sphingosine 1-phosphate |2 nationallicence | |
| 690 | 7 | |a FCS : Fetal calf serum |2 nationallicence | |
| 690 | 7 | |a siRNA : Short-interfering RNA |2 nationallicence | |
| 690 | 7 | |a SCR : Scrambled |2 nationallicence | |
| 690 | 7 | |a CM : Conditioned medium |2 nationallicence | |
| 690 | 7 | |a PBS : Phosphate-buffered saline |2 nationallicence | |
| 690 | 7 | |a DMEM : Dulbecco's modified Eagle's medium |2 nationallicence | |
| 690 | 7 | |a BSA : Bovine serum albumin |2 nationallicence | |
| 690 | 7 | |a TGFβ : Transforming growth factor beta |2 nationallicence | |
| 690 | 7 | |a SPNS2 : Spinster homolog 2 |2 nationallicence | |
| 690 | 7 | |a bFGF : Basic fibroblast growth factor |2 nationallicence | |
| 690 | 7 | |a VEGF : Vascular endothelial growth factor |2 nationallicence | |
| 690 | 7 | |a MAPK : Mitogen-activated protein kinase |2 nationallicence | |
| 690 | 7 | |a PI3K : Phosphatidylinositol 3-kinase |2 nationallicence | |
| 690 | 7 | |a SCID : Severe combined immunodeficiency |2 nationallicence | |
| 700 | 1 | |a Laurenzana |D Anna |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Cencetti |D Francesca |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Serratì |D Simona |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Bruno |D Gennaro |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Japtok |D Lukasz |u Faculty of Mathematics and Natural Science, Institute of Nutritional Science, Department of Toxicology, University of Potsdam, Arthur-Scheunert Allee 114-116, 14558, Potsdam, Nuthetal, Germany |4 aut | |
| 700 | 1 | |a Bianchini |D Francesca |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Torre |D Eugenio |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Fibbi |D Gabriella |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Del Rosso |D Mario |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Bruni |D Paola |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 700 | 1 | |a Donati |D Chiara |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | |
| 773 | 0 | |t Journal of Molecular Medicine |d Springer Berlin Heidelberg |g 93/10(2015-10-01), 1145-1157 |x 0946-2716 |q 93:10<1145 |1 2015 |2 93 |o 109 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00109-015-1292-0 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s00109-015-1292-0 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Laurenzana |D Anna |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Cencetti |D Francesca |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Serratì |D Simona |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bruno |D Gennaro |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Japtok |D Lukasz |u Faculty of Mathematics and Natural Science, Institute of Nutritional Science, Department of Toxicology, University of Potsdam, Arthur-Scheunert Allee 114-116, 14558, Potsdam, Nuthetal, Germany |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bianchini |D Francesca |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Torre |D Eugenio |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Fibbi |D Gabriella |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Del Rosso |D Mario |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bruni |D Paola |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Donati |D Chiara |u Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio”, Università di Firenze, Viale G.B. Morgagni 50, 50134, Florence, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Journal of Molecular Medicine |d Springer Berlin Heidelberg |g 93/10(2015-10-01), 1145-1157 |x 0946-2716 |q 93:10<1145 |1 2015 |2 93 |o 109 | ||